Glenmark Life Sciences Dividends and Buybacks
Dividend criteria checks 2/6
Glenmark Life Sciences is a dividend paying company with a current yield of 2.08%.
Key information
2.1%
Dividend yield
-0.0008%
Buyback Yield
| Total Shareholder Yield | 2.1% |
| Future Dividend Yield | 2.3% |
| Dividend Growth | -24.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹22.500 |
| Payout ratio | 0% |
Recent dividend and buyback updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, GLS has been paying a dividend for less than 10 years.
Growing Dividend: GLS's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Glenmark Life Sciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (GLS) | 2.1% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (GLS) (up to 3 years) | 2.3% |
Notable Dividend: GLS's dividend (2.08%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: GLS's dividend (2.08%) is in the top 25% of dividend payers in the Indian market (1.14%)
Earnings Payout to Shareholders
Earnings Coverage: Unable to calculate sustainability of dividends as GLS has not reported any payouts.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (104%), GLS's dividend payments are not well covered by cash flows.